The Cooper Companies said revenue for its fiscal second quarter ended April 30, 2025 was $1,002.3 million, up 6% year-over-year. CooperVision revenue was $669.6 million, up 5%, and CooperSurgical revenue was $332.7 million, up 8%.

1. 01

   The Cooper Companies said revenue for its fiscal second quarter ended April 30, 2025 was $1,002.3 million, up 6% year-over-year. CooperVision revenue was $669.6 million, up 5%, and CooperSurgical revenue was $332.7 million, up 8%.

2. 02

   The company said GAAP diluted earnings per share for the quarter was $0.44, consistent with the prior-year second quarter, and non-GAAP diluted EPS was $0.96, up $0.11 or 14% from the prior-year second quarter. GAAP net income for the quarter was $87.7 million.

3. 03

   The company said cash provided by operations for the quarter was $96.2 million and capital expenditures were $78.1 million, resulting in free cash flow of $18.1 million. During the quarter, it repurchased $40.6 million of common stock.

4. 04

   The Cooper Companies updated its fiscal 2025 financial guidance, saying it expects total revenue of $4,107 to $4,146 million (organic growth of 5% to 6%) and non-GAAP diluted EPS of $4.05 to $4.11.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.